Kuehn Law Encourages Investors of Amicus Therapeutics, Inc. to Contact Law Firm
(NasdaqGM:FOLD), NEW YORK, Feb. 17, 2025 (GLOBE NEWSWIRE) — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Amicus Therapeutics, Inc. (NASDAQ: FOLD) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you are a […]